Bebtelovimab, CAS 2578319-11-4

Product Description: Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Shertel T, et al. Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients. Transplantation. 2022 Oct 1;106(10):e463-e464./[2]Bebtelovimab. IMGT/mAb-DB.

CAS Number: 2578319-11-4

Molecular Weight: N/A

Compound Purity: 97.00

Research Area: Infection

Solubility: 10 mM in DMSO/H2O

Target: SARS-CoV

• SKU: MEXHY-P99103-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99103-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK